Biodesix Q3 Revenue Was USD 24.041 Million, Below IBES Estimate
Biodesix reported Q3 operating expenses of USD 30.153 million.
Related stories
Atrium Mortgage Q3 EPS Misses as Revenue Falls 11%
Atrium Mortgage reported a Q3 earnings-per-share miss and an 11% revenue decline amid a residential market slowdown.
M impact | EQUITY | Nov 05, 2026, 11:11 PM UTC
Ziff Davis Q3 Revenue Misses Estimates on Soft Demand
M impact | EQUITY | Nov 05, 2026, 11:09 PM UTC
Halozyme Reports Q3 Revenue Growth and Raises 2026 Guidance
Halozyme reported Q3 2026 revenue of $493 million, up 39.2% year over year, including royalty revenue of $341 million, up 44%. It raised full-year revenue guidance to $1.86 billion
M impact | EQUITY | Nov 05, 2026, 11:04 PM UTC
IonQ Reports Q3 Revenue of $173.8 Million, Raises 2026 Guidance
IonQ reported an adjusted loss of $0.29 per share, compared with an expected loss of $0.35. It raised full-year 2026 revenue guidance to $505 million-$515 million.
M impact | EQUITY | Nov 05, 2026, 11:03 PM UTC
nLIGHT Reports Q3 2026 Revenue of $73.8 Million, Issues Q4 Guidance
Third-quarter revenue was $73.8 million and adjusted EPS was $0.16, versus FactSet estimates of $68.2 million and $0.05, respectively. nLIGHT projected fourth-quarter revenue of $8
M impact | EQUITY | Nov 05, 2026, 11:03 PM UTC
Baytex Energy Reports Third-Quarter Results and Updates 2026–2027 Guidance
Baytex reported results for the three and nine months ended September 30, 2026, and announced an increase to its 2026 capital plan. It also provided its outlook for 2027.
M impact | EQUITY | Nov 05, 2026, 11:03 PM UTC